Related Experiment Video

Updated: Mar 29, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

16.8K

Medical management of malignant melanoma

Victoria Atkinson1

  • 1Greenslopes Private Hospital, Brisbane.

Australian Prescriber
|December 10, 2015
PubMed

Insights

Targeted therapies like BRAF and MEK inhibitors have improved outcomes for metastatic melanoma patients with BRAF mutations. Combining these drugs enhances progression-free survival, though toxicities require careful management.

Area of Science:

  • Oncology
  • Pharmacology
  • Genetics

Background:

  • Metastatic melanoma treatment has advanced with targeted therapies.
  • Approximately 50% of patients harbor BRAF gene mutations, indicating potential for targeted treatment.

Purpose of the Study:

  • To review the efficacy and safety of targeted anticancer drugs for metastatic melanoma.
  • To discuss the role of BRAF and MEK inhibitors and ipilimumab in treatment strategies.

Main Methods:

  • Review of current therapeutic options for metastatic melanoma.
  • Analysis of drug mechanisms, including BRAF inhibitors (vemurafenib, dabrafenib), MEK inhibitors (trametinib), and ipilimumab.
  • Examination of treatment outcomes and adverse effect profiles.

Main Results:

  • BRAF inhibitors and MEK inhibitors offer benefits for patients with BRAF-mutated melanoma.
  • Combination therapy with BRAF and MEK inhibitors improves progression-free survival and modifies side effects.
  • Ipilimumab modulates the immune response against tumors.
  • Common toxicities include arthralgias, fatigue, photosensitivity, squamous cell carcinomas, fever, diarrhea, pruritus, and immune-related adverse effects.

Conclusions:

  • Targeted therapies, particularly BRAF and MEK inhibitors, have significantly impacted metastatic melanoma treatment.
  • Combination strategies offer improved survival benefits.
  • Understanding and managing drug toxicities are crucial for patient care.
Keywords:
dabrafenibdacarbazineipilimumabmelanomatrametinibvemurafenib

More Related Videos

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

14.0K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K